San Francisco, CA  |  October 12-13, 2016

Precision Medicine 2.0: Evolving Partnerships, Ongoing Lab Hurdles and Developing Infrastructure

Featured Speakers

 

Stuart Hwang, Ph.D., Managing Partner, Mavericks Capital
Peter Hoehn, JD, Global Business Leader, Janssen Diagnostics

David Delaney, MD, Chief Medical Officer, Healthcare Sector, SAP

Juan Sebastian Saldivar, MD, FACMG, Chief Medical Officer, AltheaDx
pmphoto.jpg pmphotoa.jpg quinnetal.jpg

Latest Blog Post

About the Conference

One of the longest running conferences in the personalized/precision medicine space, Arrowhead's 8th Annual Personalized & Precision Medicine Conference is once again returning to the San Francisco Bay Area, on October 12th-13th. With the renewed focus on precision medicine stemming from President Obama’s 2015 initiative and multiple advances in the field on a variety of fronts, this year’s conference promises to expand your thinking and put you front and center to hear from key players and stakeholders in the field.
Eight years ago Arrowhead’s Personalized & Precision Medicine Conference focused almost exclusively on the one-on-one relationship between the pharmaceutical and diagnostic industries. Since then the field has evolved to encompass not just these bilateral relationships, but multi-stakeholder, precompetitive consortia between the industries that demonstrate their continued commitment to precision medicine and the novel ways in which they are approaching the space. This year's conference will continue to examine the components that are integral to driving precision medicine into the future, including:
▶ Optimizing Coding and Reimbursement
▶ Laboratory Developed Test (LDT) Regulation
▶ Data Privacy
▶ Innovative Partnerships Furthering Precision Medicine
▶ Crowd Sourcing Therapies
▶ Truly Individualizing Therapy
▶ Ethical/social/legal issues
▶ Transforming data into actionable guidance in the clinic
▶ Weighing clinical utility
▶ Personalized medicine at the bedside
▶ Payor evaluation of next gen sequencing
▶ Aligning labs, clinicians and payers
▶ Development of genomic medicine programs
 
 
Why Attend?
PRESENTATIONS from Physicians, Researchers, Reimbursement Experts, Payers and Leaders from the Molecular Diagnostics, Biopharmaceutical and Genome Interpretation Industries
Extended Q&A SESSIONS with Speakers
PANEL DISCUSSIONS covering a variety of topics of interest to stakeholders in personalized medicine
Numerous NETWORKING OPPORTUNITIES aided by Arrowhead's pre-conference online networking suite

Share on Social Media

  • email
  • facebook
  • linkedin
  • twitter
  • google+
  • pinterest

Download Brochure

Speaking Opportunities

Sponsor/Exhibit Opportunities

Join Conference Mailing List

The Personalized/Precision Medicine Blog

The official blog of the Annual Personalized and Precision Medicine Conference provides readers with information, insight and analysis regarding the field of personalized and precision medicine, genomics, genomic interpretation and the evolution of healthcare in the post-genomic era.
Font size: +

Key Leaders in Precision & Personalized Medicine To Meet This Fall for the 8th Annual Personalized & Precision Medicine Conference

Arrowhead Publishers has announced the addition of several new speakers to the agenda for the upcoming 8th Annual Personalized & Precision Medicine Conference, taking place on October 12-13, 2016 in the San Francisco Bay Area.
 
As one of the longest running conferences in the industry, this conference will gather a variety of key thought leaders in the private and public sectors to gain multi-stakeholder perspectives on this constantly evolving industry.
 
“The Annual Personalized and Precision Medicine Conference continues to be a vital meeting place for diagnostics companies, laboratories and other companies and organizations whose goal is the successful implementation of precision medicine at the local, national and global level,” said John Waslif, Managing Director of Arrowhead Publishers, the organizers of the conference.
 
“We are pleased to be able to bring together leaders from some of the most innovative life science companies in the world to address key areas related to the advancement of precision medicine, including reimbursement, value-based medicine, informatics, pharmacogenomics, pharmacogenetics, precision medicine clinical trials, and companion diagnostics.”
 
In addition to presentations, there will be a variety of extended Q&A sessions, panel discussions, and networking opportunities. One unique aspect of this conference is the pre-conference online networking suite, which provides a platform to ensure professional introductions can be established before the event.
 
With over 20 presenters, the 8th Annual Conference will focus on several key themes, including companion diagnostics, genomics data infrastructure, and emerging reimbursement policies. 
 
Kristine Ashcraft, Chief Executive Officer, Genelex, will be presenting on the crucial nature of the shift to value-based care within the healthcare system. With a variety of evolving regulatory and quality initiatives, Ashcraft will discuss the variety of factors that will ensure the success of precision medicine.
 
Dr. Jeremy Stuart of Selah Genomics will be highlighting the community health perspective of precision medicine. He will cover several case examples of precision-guided tests, and elaborate on the current solutions and challenges that exist in the precision medicine industry.
 
While genomic and related technological discoveries have allowed for revolutionary advances in personalized medicine, it is crucial to maintain a more long-term goal that these trials must be replicated on a larger-scale in the near future. Dr. Nicholas Schork from J. Craig Venter Institute believes that we must adapt the design of clinical trials for personalized medicine with this goal in mind in order to achieve long-term success.
 
Mobile technologies have the potential to revolutionize how we monitor and collect data medical data, but we are not yet able to achieve maximal impact due to growing concern over data privacy of individuals. John Wilbanks of Sage Bionetworks believes that there can be a mutually beneficial relationship created for all invidivuals involved. At the conference, WIlbanks will discuss his strong belief that creating social contracts between participants and researchers, while allowing maximal utility from the data systems, is key into furthering personalized and precision medicine. He will provide a recent case study which leveraged Apple’s ResearchKit framework, and will elaborate upon why this was a success for medical research.
 
One of the founders of Sinopia Biosciences, Aarash Bordbar, will be sharing his recent advances in personalized network models, and how they have led towards a better understanding of the side effects of pharmaceuticals. Dr. Bordbar’s presentation will provide an excellent opportunity to gain further insight into how we understand both individual patient physiology and pharmaceutical compounds in relation to side effects.
 
For more information on the 8th Annual Personalized & Precision Medicine Conference, please visit: http://personalizedmedicinepartnerships.com
 
For more conference information, please contact:
 
John Waslif: Managing Director
Arrowhead Publishers
866-945-0263
This email address is being protected from spambots. You need JavaScript enabled to view it.
Rate this blog entry:
Challenges and Opportunities in Precision Medicine...

    Testimonials from Past Conferences

    Being new to Pharmacogenomics and genetic testing, the conference was very informative. Definitely a learning experience.

    Karla S. Muller, </strong>Billing Specialist<strong>, Frontier Toxicology

    Karla S. Muller, Billing Specialist, Frontier Toxicology

    Very valuable focused sessions that provide actionable content.

    Michael Giske, Epic Sciences

    Michael Giske, Epic Sciences

    An excellent and valuable conference.

    Michelle Chen, President, Rayner-Chen Advisory

    Michelle Chen, President, Rayner-Chen Advisory

    This was my first PPMC and I was absolutely pleased with it. It was an amazing opportunity to network with other companies that are breaking into the healthcare industry, create partnerships and share challenges and hardships and try to find a way around them.

    Shelley Herek, Director of Sales, LifeMap Sciences

    Shelley Herek, Director of Sales, LifeMap Sciences

    An excellent conference that concentrates on the benefits and risks associated with the use of genetic information to provide personalized diagnostics and therapeutic options to the patient. Great coverage of social, practical and regulatory issues.

    Glenn Braunstein, MD, Chief Medical Officer, Pathway Genomics

    Glenn Braunstein, MD, Chief Medical Officer, Pathway Genomics

    Best multiple perspective insider's view of what's involved in implementing precision medicine that I've encountered thus far.

    Lee Watkins, Jr., Director of Bioinformatics and IT, Johns Hopkins University Institute of Genomic Medicine

    Lee Watkins, Jr., Director of Bioinformatics and IT, Johns Hopkins University Institute of Genomic Medicine

    Very well organized, relevant and extremely useful conference.

    Igor Keselman, Chief Operating Officer, Quremedy

    Igor Keselman, Chief Operating Officer, Quremedy

    Speakers provided a lot of deep domain expertise in diagnostics, oncology, regulatory, and patents related to personalized medicine.

    Gitte Pedersen, Chief Executive Officer, Genomic Expression

    Gitte Pedersen, Chief Executive Officer, Genomic Expression

    Networking Opportunities

     
    You will have multiple chances to network and meet with others in the field of personalized medicine during the conference. There will be an online networking tool available before the conference even begins!
    Attendees will have the opportunity to meet other attendees through the following networking services:
    ► Our CONFERENCE NETWORKING SITE is online weeks prior to the event. Attendees can schedule one-on-one meetings prior to the conference and print out a schedule of meeting times during the conference.
    ► EXTENDED NETWORKING BREAKS. These will give attendees the chance to meet those with whom they many not have set up meetings.
    ► EVENING RECEPTION. This will give attendees the chance to mingle with other professionals after a day full of speakers, meetings, and thought-provoking topics.
    ► SPEAKER Q&A SESSIONS. This will afford attendees the opportunity to ask additional questions of our speakers.

    Who Attends

    20/20 GeneSystems, Inc. | 55th Parallel, LLC | Abbott Molecular | Abraxis Bioscience | ActX | Affymetrix, Inc. | Agendia, Inc | AlliedPath, Inc. | Almac Diagnostics | Alpha Genomix | Amgen | AncestryDNA | Appistry | Apple Tree Partners | Applied Biosystems | Arsenal Capital Partners | AssureRx Health, Inc. | AstraZeneca Pharamceuticals | Asuragen | Athena Diagnostics | Atlantic Health | Aureon Laboratories | Axial Biotech | BCBST | BCM Technologies | BD Becton Dickinson | Berkeley HeartLab, Inc. | Bio-X Center, China Fudan University | BIOCRATES Life Sciences | Biodesix, Inc. | BioM GmbH BioMarker Strategies | bioMerieux, Inc. | BioNano Genomics, Inc. | Biostat Solutions | BioTrove Inc. | BNA | Boston Biomedical Consultants | Boston Cancer Policy Institute, Inc | Boston Healthcare Associates | Brigham and Women's Hospital | Bristol Myers Squibb | BSG Institute | Cancer Care Ontario | Cedar Associates, LLC | Cedars-Sinai Medical Center | Celera Diagnostics | Chamberlain Medical Enterprises, Inc | Charite Berlin | CHU Sainte-Justine Chulalongkorn University | CIRANO | Clemson | Cleveland Clinic | Clinical Reference Laboratory | Coimbra Genomics | Consultant Core Principle Solutions | Coriell Institute for Medical Research | Covington & Burling | Crescendo Bioscience | CTG | Current Partnering | Cylex Inc | Cynergene | Decatur Memorial Hospital | deCode Genetics | Deloitte Center for Health Solutions | DHCS | Diaceutics | Diamyd Medical AB | DiTherea, Inc. | DNA Direct | DNA Genotek | Duke University | Easton Associates | Eli Lilly and Company | Elsevier | Emerson College | EPEMED | Eurolab Clinik | European Commission | F. Hoffmann-La Roche | FDA | Foley and Hoag | Foley and Lardner | Forest Laboratories, Inc. | Foundation Medicine | Fox Chase Cancer Center | Frost & Sullivan | GE Heathcare | Gen-Probe Inc | GeneDX, Inc. | Genizon Biosciences | Génome Québec | Genome Web LLC | Genomic Health, Inc. | Genomic Healthcare Strategies | Gilead Sciences, Inc | GlaxoSmithKline | Google | Green Cross Reference Lab | Hackensack University Medical Center | Harvard Medical School | Health Canada | Health Discovery Corporation | Helix Health Advisors | HIAE HillCo Health | Hopital Jean Verdier | Houston Methodist Hospital Research Institute | Humana | Ibiomedtech | Ikaria Industry Canada | Interleukin Genetics | ITHW Inc. | Jackson Laboratory for Genomic Medicine | Johns Hopkins University | JWMS | Labceutics | LabCorp | Laboratorio Genesis-MANLAB | Landspitali - University of Iceland | Life Technologies | Lilly Oncology | LS Foresight Institute, Lund University | Main Line Ventures | Mass Medical Angels | Massachusetts General Hospital | Massachusetts Institute of Technology | Max Planck Innovation GmbH | Mayo Clinic | MD Anderson Cancer Center | Mead Johnson Nutrition | Medco Health Solutions, Inc | Medical College of Wisconsin | Medical Device Consultants | Medicine Professional Corp. Giampiero Bartolucci | MedImmune, LLC | MEI Molecular | Memorial Sloan Kettering Cancer Center | Merck & Co. | Metamark Genetics | Millennium Laboratories | Millennium Pharmaceuticals | MindSpec Inc. | Mission Health | MolecularMD | Morristown Medical Center | Mount Sinai Hospital | MPEG LA | Myriad Genetic Laboratories, Inc. | Myriad Genetics Inc. | National Human Genome Institute | National Institute of Standards & Technology | Nature Medicine | NCTR/FDA | NeoGenomics Laboratories | NephroGenex, Inc. | Neurosurgery / KUH NeuroCenter | New York Presbyterian - Columbia New York University | NIDDK, National Institutes of Health | Nigist Elleni Mohammed Memorial Hospital | NIH National Library of Medicine | NCBI NIH/NHGRI | Nodality | Norwegian University of Science and Technology | Ohio State University College of Medicine | Oncology Solutions, LLC | OncoMethylome Sciences | Onyx Pharmaceuticals | Ortho Clinical Diagnostics | OSI Pharmaceuticals | Pamlab, LLC | Partners Health Care Ctr for Personalized Genetic Medicine Partners Healthcare | Pearson Investment Co. | PerkinElmer Inc. | Permedx Consulting Ltd. | Pfizer | PGxHealth | PricewaterhouseCoopers | Proskauer Rose LLP | Proventys, Inc. | Qiagen Manchester | RainDance Technologies | Randox Laboratories Ltd | Redmile Group, LLC | Regeneron Pharmaceuticals, Inc. | Regis College | Roche Molecular Diagnostics Roche Palo Alto | Roche Products Ltd | Roswell Park Cancer Institute | Rowan-SOM | Saladax Biomedical Inc. | Sanford Health | sanofi-aventis | SBIR Development Center | NCI Science Translational Medicine | Scientia Advisors | Seoul National University Hospital | Seqster, Inc. | Siemens Venture Capital | Simmons and Simmons | Sinoptia | SK Telecom Social & Scientific Systems | Sterne, Kessler, Goldstein & Fox | Stony Brook University | Stradley Ronon Stevens & Young, LLP | Suez Canal University | Synergenz BioScience, Inc | Tethys Bioscience | TGen | The Critical Path Institute | The Houston Methodist Research Institiute | The Jackson Laboratory | The PROOF Centre | Therapak Corporation | Third Rock Ventures | Thunderbird School of Global Management | UCL Institute of Child Health | UnitedHealth Group | University of Chicago | University of Delaware | University of Iowa | University of Louisville | University of North Carolina | University of Pittsburgh | University of Toronto, St. Michael's Hospital | University of Virginia | Veridex | Virginia Commonwealth University | VirtualScopics Inc. | Washington Hospital Center | MedStar Health | XIFIN, Inc.

    Who Will You Meet

    • Pharmaceutical Company Leaders
    • Diagnostic Company Leaders
    • Genome Interpretation Experts
    • Genome Sequencing Pioneers
    • Biotech Leaders
    • Healthcare Providers
    • Academicians
    • Consultants
    • Government Leaders
    • Health Insurance Executives
    • Investors
    • Venture Capitalists

    Sponsor/Exhibit

     
    MULTIPLE NETWORKING OPPORTUNITIES Before, During and After the Summit
    ACCESS To A Contact List Of Highly Targeted Personalized Medicine Leaders
    PROMOTIONAL PLACEMENT Across A Variety Of Platforms
    ATTEND Conference Presentations Side By Side With Attendees
    BUILD Brand Awareness Within a Network of Key Organziations
     For More Information, CLICK HERE

    About Us

    Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at www.arrowheadpublishers.com.

    Contact Us

    For general information about the conference, please contact us at:
     This email address is being protected from spambots. You need JavaScript enabled to view it.
     +866.945.0263
     +866.945.0263
     5780 Lincoln Drive, Suite 205, Edina, Minnesota 55436 USA